Hyderabad-based Creative Bee trained rural women in Tuticorin to design lifestyle products using water hyacinth fibres. Another training programme in Bihar is in the offing

Research suggests that gut bacteria may directly affect brain structure and function, offering new ways to treat multiple sclerosis and psychiatric conditions

Far from being silent partners that merely help to digest food, the bacteria in your gut may also be exerting subtle influences on your thoughts, moods, and behaviour. And according to a new study from researchers at University College Cork, your gut microbes might affect the structure and function of the brain in a more direct way, by regulating myelination, the process by which nerve fibres are insulated so that they can conduct impulses properly.

The surprising new findings, published today in the journal Translational Psychiatry, provide what is perhaps the strongest evidence yet that gut bacteria can have a direct physical effect on the brain, and suggest that it may one day be possible to treat debilitating demyelinating diseases such as multiple sclerosis, and even psychiatric disorders, by altering the composition of the gut’s microbial menagerie in some way or another.

Related: Brain’s immune cells hyperactive in schizophrenia

Related: White matter might matter much more than we thought | Mo Costandi

While the name may be a little inappropriate at a time during the coronavirus pandemic, the Alyen 988 sure looks stunning draped in carbon-fibre and its lightweight magnesium frame.

2. It was stated that OP-1 is an association of man-made fibre manufacturers in India; OP-2 is the largest producer and seller of Viscose Staple Fibre (VSF) in India; OP-3 is a company registered in Thailand and promoted by OP-2; and OP-4 is a company belonging to the Aditya Birla Group operating in Indonesia and engaged in the business of manufacturing, selling and exporting VSF to customers located in the US, Europe, Turkey, Japan, Korea, China and other countries in both textile and non-woven segments.

3. The Informant alleged that OP-2 is the sole producer of VSF having a market share of almost 100% in India and it is misusing its sole position in the domestic market to squeeze the textile industry consumers. With regard to OP-3 and OP-4, it was alleged that OP-2 imports and markets its products and Case No. 62 of 2016 2 Public Version OP-3, operating from Thailand and OP-4, operating from Indonesia, have joined hands to exploit the Indian market.

Tiny polyester fibres, which are washed into rivers, lakes and seas every time we do our laundry could cause more harm to animals than plastic microbeads, finds a new study. The researchers looked at the effect of microbeads and fibres on a small crustacean called Ceriodaphnia dubia, which lives in freshwater lakes. They found that although both types of plastic were toxic, microfibres caused more harm. Both microplastics stunted the growth of the animals, and reduced their ability to have offspring; microfibres, however, did this to a greater degree, and also caused noticeable deformities in the crustacean’s body and antennae.

Cystic Fibrosis Foundation of Maryland hosts its 5th annual Actavis+Allergan Cycle for life fundraiser to continue the fight in finding cure for CF.

The tenth annual fundraiser returned to Puerto Vallarta surpassing last year's results by $150,000

Developed by a fitness instructor coping with chronic pain & fatigue herself, Cocolime Fitness is bringing real relief to people around the world suffering with debilitating health issues.

The new partnership extends to leading voices in the uterine fibroids patient advocacy community including the Atlanta-based White Dress Project and D.C.-based CARE About Fibroids.

Focused Update Highlights: Newer anticoagulants, known as non-vitamin K oral anticoagulants (NOACs), are recommended over the traditional warfarin to prevent stroke in people with atrial fibrillation (AFib). Weight loss is recommended for overweight or obese people with AFib.

Statement Highlights: Improving lifestyle habits – such as attaining and maintaining a healthy body weight and getting regular, moderate physical activity – may be useful additions to physician-guided management of atrial fibrillation (AF), a serious...

In this paper, we develop the theory for classifying all the geometric fibrations of compact, connected, flat $n$-orbifolds, over a 1-orbifold, up to affine equivalence. We apply our classification theory to classify all the geometric fibrations of compact, connected, flat $2$-orbifolds, over a 1-orbifold, up to affine equivalence. This paper is an essential part of our project to give a geometric proof of the classification of all closed flat 4-manifolds.

The invention relates to a melt composition for the production of man-made vitreous fibers and man-made vitreous fibers comprising the following oxides, by weight of composition: SiO239-43 weight %Al2O320-23 weight %TiO2up to 1.5 weight %Fe2O35-9 weight %, preferably 5-8 weight %CaO8-18 weight %MgO5-7 weight %Na2Oup to 10 weight %, preferably 2-7 weight %K2Oup to 10 weight %, preferably 3-7 weight %P2O5up to 2%MnOup to 2%R2Oup to 10 weight % wherein the proportion of Fe(2+) is greater than 80% based on total Fe and is preferably at least 90%, more preferably at least 95% and most preferably at least 97% based on total Fe.

A retractable screw-type stimulation or defibrillation intracardiac lead is disclosed. According to one embodiment, the lead comprises a flexible hollow sheath (12) having at its distal end a lead head (10) and a connector (66) at its proximal end. The connector comprises a pin (62) connected to a lead head electrode (18). The lead head comprises a tubular body (28), at least one electrode (18, 20) for stimulation or defibrillation, a moving element translationally and rotationally moving within the tubular body in a helical motion, an anchoring screw (24) axially moving with respect to the tubular body, and a deployment mechanism (22) to deploy the anchoring screw out of the tubular body (28). The lead is a co-radial type, and the moving element (26) secured to the anchoring screw is connected to the tubular body (28) by a helical guide (46) and a coupling finger (56) protruding between two successive turns of the helical guide (46) for transforming a rotary movement imparted to the lead body in a deployment or retraction movement of the moving element (26). The helical guide (46) is resiliently compressible, with a free end (52) with a flat area (54) facing a flange (38) in vis-à-vis, so as to pinch the coupling finger (56) and to perform the function of a clutch limiting the torque transmitted to the anchoring screw by the rotation of the lead body, even in case of continuation of this rotation.

Devices, systems, and methods for treating a heart of a patient may make use of structures which limit a size of a chamber of the heart, such as by deploying a tensile member to bring a wall of the heart toward (optionally into contact with) a septum of the heart. The implant may include an electrode or other structure for applying pacing signals to one or both ventricles of the heart, for defibrillating the heart, for sensing beating of the heart or the like. A wireless telemetry and control system may allowing the implant to treat congestive heart failure, monitor the results of the treatment, and apply appropriate electrical stimulation.

The present invention provides compounds having the general structural formula (I), and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving abnormal or excessive fibrosis.

The present invention is related to the use of secretagogue peptides repeatedly administered as part of a pharmaceutical composition that prevent and eradicate the deposition of pathological fibrotic material in parenchymal tissues of internal organs like the liver, lungs, esophagus, small intestine, kidneys, blood vessels, joints, and other systemic forms of cutaneous fibrosis of any etiopathogenesis. Additionally, these peptides prevent and eradicate deposition of amiloid and hyaline materials in any of their correspondent chemical forms and tissue manifestations in the brain, cerebellum, blood vessels, liver, intestines, kidneys, spleen, pancreas, joints and the skin, among others. By this way, cellular, tissular and organ dysfunctions generated by these depositions are corrected. The peptides of the present invention are infiltrated or topically applied, contributing to prevent and eradicate keloids and hypertrophic scars in the skin, derived as sequelae of burns and other cutaneous trauma.

The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of aortic fibrosis and other associated conditions.

Disclosed is a drug effective in the treatment of fibromyalgia. Basically, the disclosed therapeutic agent was created on the basis of experiments showing improvement in symptoms when etanercept was administered to patients suffering from fibromyalgia. Etanercept is known as a therapeutic agent for rheumatoid arthritis, and the JFIQ score of patients not suffering from fibromyalgia improved considerably in the preferred embodiment. In other words, a therapeutic agent for fibromyalgia is disclosed that contains etanercept as an active ingredient in an effective amount.

Method of manufacturing a fibre-reinforced composite moulding, the method comprising the steps of: (a) disposing at least one layer of fibrous reinforcing material within a mould; (b) disposing at least one pre-preg layer adiacent to the fibrous reinforcing material, the pre-preg layer comprising fibrous reinforcement at least partially impregnated with uncured first resin material, to form a laminar assembly of the at least one layer of fibrous reinforcing material and the at least one pre-preg layer within the mould; (c) applying a vacuum to the assembly; (d) infusing a flowable uncured second resin material, under the vacuum, into the at least one layer of fibrous reinforcing material; and (e) curing the first and second resin materials at least partially simultaneously to form the fibre-reinforced composite moulding which comprises at least one first structural portion formed from the fibrous reinforcement and the cured first resin material bonded to at least one second structural portion formed from the at least one layer of fibrous reinforcing material and the cured second resin material.

Compositions of thermoplastic polyesters containing dispersed nanoparticles of fibrous clay are made by polymerizing the polyester precursors in the presence of exfoliated fibrous clay that has not been organically modified. The compositions have good physical properties and can be melt molded into various articles. Many of these articles may be coated (painted) and are especially useful for appearance parts such as visible exterior automotive body parts.

Configurations for simulation of motions or movement in a health training mannequin for teaching purposes are disclosed. A cardiac defibrillation response simulation apparatus is configured to be housed separately from but interfaced with a health training mannequin to induce motion symptomatic response to electrical shock in the mannequin. In one embodiment a system comprises a motion inducer comprising a housing, an interface structure, and an actuator, wherein the interface structure is coupled to the actuator, movable relative to the housing, and configured to interface with a portion of a health training mannequin to induce motion in at least one portion of the health training mannequin. In another embodiment a method comprises interfacing a portion of a health training mannequin with an interface structure, the interface structure being coupled to an actuator and movable relative to a housing coupled to the actuator, the housing not being housed within a portion of the health training mannequin. Various hardware configurations are presented.

A papermaking machine for the production of a fibrous web including a plurality of rollers and a structured fabric moving along the rollers. The structured fabric includes a plurality of weft yarns and a plurality of warp yarns woven with the plurality of weft yarns to produce a weave pattern, the plurality of warp yarns being a plurality of paired warp yarn sets. Each paired warp yarn set including a first warp yarn and a second warp yarn. Within the weave pattern the first warp yarn forms a float over at least four weft yarns and weaves with a single weft yarn immediately adjacent with the float. The second warp yarn having an inverse pattern to the first warp yarn, with the second warp yarn weaving with another single weft yarn that is not adjacent to the single weft yarn with which the first warp yarn is woven.

An anti-“Methicillin-Resistant Staphylococcus Aureus (MRSA)” chitosan containing antibacterial High Wet Modulus (HWM) rayon fiber textile for medical usage is made of the steps as following: chitin flakes made from natural shrimp or crab shells are deacetylated to generate chitosan with a high deacetylation degree of 90% or more. Next chitosan is dissolved in acetic acid and regenerated by caustic soda to form a chitosan antibacterial nanoparticles slurry, then added to HWM viscose rayon process, and spinning to produce a chitosan containing antibacterial HWM rayon fiber. The antibacterial amino groups of chitosan and the hydroxyl groups of rayon cellulose combine together via hydrogen bonding. Therefore, the fiber becomes the anti-MRSA antibacterial HWM rayon fiber containing amino groups (—NH3+). Finally the resulting HWM rayon fiber is conducted via a yarn spinning or/and weaving process to procure a medical textile with chitosan content.

The present invention relates to a device for applying a fluid or pasty product to keratin fibers, comprising an elongate core (1) extending on a longitudinal axis XX. Advantageously, the device additionally comprises at least one pliant and flexible rod (2), which is oriented longitudinally and is embedded, at least at a first and a second point, on said longitudinal core (1), so as to form at least one zone of flexion perpendicular to the longitudinal axis XX; it is made in one piece and preferably from a plastic material.

A tubular fibrous architecture is disclosed. According to one aspect, the tubular fibrous architecture includes a closed tubular part in at least one of its ends or bottom. The closed tubular part includes an architecture in which a textile material, such as a thread, roving, ribbon or bundle of threads, is continuously output from the bottom. Each textile material that is output from the bottom is continuously wound about the tubular part. All of the textile materials at the junction between the bottom and the remainder of the tubular part are continuous and there is a continuous geometric transition between the bottom architecture and the architecture of the remainder of the tubular part such that the textile materials in the tubular part cross over. A method of making such a tubular fibrous architecture is also disclosed.

A cover for the gap in an automobile automatic gear shift assembly is presented. The gap cover is formed from a single molded housing with inward pointing fibrillations. These fibrillations act as fingers to cover the hole created when the multi position mechanism is moved from one position to another. The fibrillations are assisted back to their original position through (1) physical properties of the advanced polymeric substance used to mold the housing and (2) through the interactions of assisting tabs formed on the back side of the fibrillations, which act as springs.

A method of producing a finely fibrous cellulose composite prepreg sheet, sheet or laminate sheet, the method including a mixing an emulsion of a reactive compound with an aqueous suspension containing a finely fibrous cellulose to prepare a mixed liquid dewatering the mixed liquid by filtration on a porous substrate to form a water-containing sheet; and heating and drying the water-containing sheet. A method of producing a finely fibrous cellulose composite sheet, the method including subjecting the finely fibrous cellulose composite prepreg sheet produced by the method described above to a curing treatment.

Fibrous structures that exhibit a Free Fiber End Count greater than the Free Fiber End Count of known fibrous structures in the range of free fiber end lengths of from about 0.10 mm to about 0.75 mm as determined by the Free Fiber End Test Method, and sanitary tissue products comprising same and methods for making same are provided.

A papermaking belt. The papermaking belt has a reinforcing element comprising a surface and a plurality of irregularly shaped, discrete raised portions extending from portions of the surface of the reinforcing element. The discrete raised portions are situated in an irregular pattern, wherein each of the discrete raised portions has a major axis, A, and a minor axis, B, and wherein the length of the major axis, A, is greater than or equal to the length of the minor axis, B; and a substantially continuous deflection conduit defines at least some of the discrete raised portions.

The present invention relates to the use of the miRNA expression profile, particularly of miR-199a-5p, and the target genes regulated thereby for the diagnosis, prognosis and use of miR-199a-5p inhibitors for treating fibroproliferative disorders.

Fibrous structures that exhibit a novel combination of properties and to methods for making such fibrous structures are provided.

The present invention relates to protein compositions. In particular, the invention relates to a method for the production of a composition comprising casein fibrils. Further aspects of the invention area composition comprising casein fibrils, the use of such a composition and a food product comprising the composition.

Fertilizer granules and methods of producing fertilizer granules. The fertilizer granules are formed from a fertilizer composition, such as a phosphate fertilizer, includes a fibrous material for the purpose of increasing the granule strength preventing or reducing attrition or dusting formation during storage, transport, and/or handling of the fertilizer. Dust formation can be reduced fifty percent or more. The base fertilizer composition can include a phosphate fertilizer, such as monoammonium phosphate (MAP) or diammonium phosphate (DAP), and optionally one or more micronutrients or secondary nutrients, such as elemental sulfur. The fibrous material is pulp or paper sludge, for example.

A device for preventing jamming of a fibrous material subject to a compressive treatment in a stuffing chamber defined by a feed roll and a retard roll. The device includes an impact blade and a stabilizing apparatus. The impact blade is rigid and interchangeable. The stabilizing apparatus stabilizes the impact blade against moving away from the feed roll to prevent the jamming of the fibrous material between the feed roll and the impact blade during the compressive treatment of the fibrous material.

The present invention relates to an aqueous anti-dusting formulation for use in combination with a binder in the manufacture of fiber wool insulation, the formula comprising: a) oil; b) polyvinyl alcohol; and c) water. The invention further relates to a method for preparing a glass or mineral fiber product with the anti-dusting formulations and to products of the process.

The present invention provides a novel cationized microfibrillated plant fiber and a method for manufacturing the same. A cationic microfibrillated plant fiber that is cationically modified with a quaternary-ammonium-group-containing compound, and that has an average diameter of 4 to 200 nm.

The present invention relates to metal coated nano-fibres obtained by a process that includes electrospinning and to the use of said metal coated nano-fibres. The process is characterised in that a polymer nano-fibre with functional groups providing the binding ability to a reducing reagent is prepared by electrospinning at ambient conditions. Then this is contacted with a reducing agent, thereby opening the epoxy ring on the surface of polymer nano-fibre and replacing with the reducing agent and the reducing agent modified film is reacted with metal solution in alkaline media. Finally the electrospun mat is treated with water to open the epoxy rings in the structure and crosslinking the chains to provide integrity.

The present invention refers to a process of making a fibrous structure, wherein roughly graded material is provided to rotating, apertured drums. The drums have at least one needle roll in their inside. The roughly graded material is agitated inside the drums, whereby fibers or small fiber clusters are separated from each other. These fibers and small fiber clusters are flung through the apertures to the outside of the drum, where they are directed onto a foraminous carrier to form a fibrous structure. The fibrous structures are especially useful in absorbent articles.